UE LifeSciences Inc.

PHILADELPHIA, PA · CIK 0001683096 · Medtech · Private

AI-powered diagnostic software for early detection of breast and cervical cancer

uelifesciences.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$480K
1 Form D · Nov 2021
58 months since last filing
Contracts
—
No federal contracts on record
Patents
5
0 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$480,308
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1089Eye Academy of America Ltd.—$4.0M
1090smallTalk Technology, Inc.—$1.1M
1091Bansen Labs LLC—$300K
1092UE LifeSciences Inc.—$480K
1093Amulet, PBC—$5.2M
1094Nielsen BioSciences, Inc.—$12M
1095Motus GI Holdings, Inc.—$26M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Ari BrooksDirector
  • Matthew CampisiExecutive Officer · Promoter
  • Suren GulrajaniDirector
  • Bhaumik SanghviExecutive Officer · Promoter
  • Mihir ShahDirector · Executive Officer · Promoter

Patents

USPTO · 0 granted of 5
  • System And Method For Measuring Tissue Parameters By Use Of Capacitive Tactile Sensorapplication
  • Chromatic Profile Spatial Mappingapplication
  • Chromatic Profile Spatial Mappingapplication
  • System And Method For Measuring Tissue Parameters By Use Of Capacitive Tactile Sensorapplication
  • System And Method For Measuring Tissue Parameters By Use Of Capacitive Tactile Sensorapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.